Skip to main content
. Author manuscript; available in PMC: 2013 May 9.
Published in final edited form as: Surgery. 2012 Aug;152(2):218–226. doi: 10.1016/j.surg.2012.05.037

Fig. 3.

Fig. 3

Specific subgroups of patients with metabolic syndrome demonstrated a greater risk of death. Specifically, the risk of postoperative death among patients with metabolic syndrome was increased for patients undergoing liver resection to treat either liver metastasis (A) or HCC (B).